The Past, Present, and Future of Cancer Cytogenetics
1. Edition March 2022
208 Pages, Hardcover
Wiley & Sons Ltd
Price: 115,00 €
Price incl. VAT, excl. Shipping
Explore the past, present, and future of cancer cytogenetics
In Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics, globally renowned researchers Drs. Sverre Heim and Felix Mitelman deliver a state-of-the-art review of how cancer cytogenetic analyses have contributed to an improved understanding of tumorigenesis as well as to the diagnosis and treatment of cancer patients. The book also discusses how cytogenetics - the study of chromosomes - meets, interacts with, and cross-fertilizes other investigative technologies, including molecular somatic cell genetics.
The book provides an impetus to think more deeply about the role chromosomes, and their abnormalities, play in health and disease, especially in neoplastic disorders. From which origins did cytogenetics develop? How did the finding of acquired chromosomal abnormalities in cells of leukemias and solid tumors influence our understanding of cancer as a biological process? How was information of this nature put to good use in the clinical management of cancer patients?
Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics offers readers:
* A thorough introduction to ancient theories of disease, the advent of cellular pathology, and how a scientific interest in chromosomes developed
* Comprehensive exploration of the conceptual importance of Theodor Boveri and his somatic mutation theory of cancer
* A detailed chronological resume of cancer cytogenetic discoveries during the 20th century
* In-depth discussions of the role of chromosome abnormalities, oncogenes, and tumor suppressor genes in leukemias, lymphomas, and solid tumors, together with a survey of what chromosome analyses have revealed about the clonal evolution of neoplastic cell populations
* A discussion of the importance of pathogenetic classifications of neoplastic diseases, the role chromosome abnormalities play in this context, and which technological breakthroughs can be expected in chromosome-oriented cancer research
Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics was written for everyone with a scientific or clinical interest in cancer, especially how acquired chromosome abnormalities lead to neoplastic transformation. The book teaches how cytogenetic analyses contribute to a better understanding of tumorigenesis, but also how the finding of specific chromosome aberrations can be crucial for the diagnosis, prognosis, and management of cancer patients.
PART ONE: PAST
Chapter 1 Understanding disease: ancient theories
Chapter 2 The advent of cellular pathology
Chapter 3 The colored bodies of cell nuclei: chromosomes and heredity
Chapter 4 Boveri and the somatic mutation theory of cancer
Chapter 5 Cytogenetics from 1914 to 1960: slow progress followed by serendipitous methodological breakthroughs leading to important
Chapter 6 The first cancer-specific chromosome aberrations: Ph1 and others
PART TWO: PRESENT
Chapter 7 The banding revolution: cancer cytogenetics in the 1970s
Chapter 8 Chasing correlations: chromosomes and oncogenes in leukemias and lymphomas
Chapter 9 Solid tumor cytogenetics
Chapter 10 Gains, losses, and rearrangements of genomic material: pathogenetic considerations
Chapter 11 Morphology meets chemistry: integration of molecular genetics into the cytogenetic search for cancer-specific chromosome aberrations
Chapter 12 Unravelling the clonal evolution of neoplastic cell populations
Chapter 13 Clinical usefulness
PART THREE: FUTURE
Chapter 14 Toward a pathogenetic classification of cancer
Chapter 15 Where there is structure, there is function
Chapter 16 Which resolution level is optimally suited to answer which questions? Seeing never goes out of fashion...
Chapter 17 Are new technological breakthroughs on the horizon?
Felix Mitelman is an elected member of the Royal Swedish Academy of Sciences and the American Academy of Arts and Sciences, as well as the Editor-in-Chief and Founder of Genes, Chromosomes & Cancer.